Stock listing
OTC:INTI Inhibitor Therapeutics Inc. Stock
Follow Inhibitor Therapeutics Inc. into a list and get an email when it puts out news.
Share price · OTC:INTI
$0.08 USD +0.00 (+1.3%)
Close on Nov 10, 2026
- Day range
- $0.08 – $0.08 USDNov 10, 2026
- Volume
- 80,000 sharesNov 10, 2026
- Market cap
- $13.98M USDAt the close on Nov 10, 2026 · price × 174.8M shares outstanding
- 52-week range
- $0.04 – $0.124 USDLowest and highest trades, Nov 11, 2025 – Nov 10, 2026
- Traded on an average day
- $348 USDMedian day 0 shares · 34 days with no trades · last 3 months, Aug 10, 2026 – Nov 10, 2026

Daily closes
Last 3 months, Aug 10, 2026 – Nov 10, 2026 · OTC:INTI · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.08 | +0.001 | +1.3% | $0.08 | $0.08 | $0.08 | 80,000 | |
| $0.079 | 0.00 | 0.0% | $0.079 | $0.079 | $0.079 | 0 | |
| $0.079 | 0.00 | 0.0% | $0.079 | $0.079 | $0.079 | 0 | |
| $0.079 | 0.00 | 0.0% | $0.079 | $0.079 | $0.079 | 0 | |
| $0.079 | -0.018 | -18.6% | $0.059 | $0.079 | $0.059 | 1,500 | |
| $0.097 | 0.00 | 0.0% | $0.097 | $0.097 | $0.097 | 0 | |
| $0.097 | +0.032 | +49.2% | $0.097 | $0.097 | $0.097 | 2,000 | |
| $0.065 | -0.015 | -18.8% | $0.065 | $0.065 | $0.065 | 1,000 | |
| $0.08 | 0.00 | 0.0% | $0.08 | $0.08 | $0.08 | 0 | |
| $0.08 | +0.019 | +31.1% | $0.076 | $0.08 | $0.076 | 8,200 | |
| $0.061 | -0.01 | -14.1% | $0.098 | $0.098 | $0.061 | 147,700 | |
| $0.071 | -0.018 | -20.2% | $0.071 | $0.071 | $0.071 | 100 | |
| $0.089 | +0.001 | +1.1% | $0.08 | $0.089 | $0.08 | 1,500 | |
| $0.088 | -0.022 | -20.0% | $0.059 | $0.089 | $0.059 | 2,200 | |
| $0.11 | 0.00 | 0.0% | $0.11 | $0.11 | $0.11 | 0 | |
| $0.11 | 0.00 | 0.0% | $0.11 | $0.11 | $0.11 | 0 | |
| $0.11 | +0.012 | +12.2% | $0.069 | $0.11 | $0.061 | 3,900 | |
| $0.098 | 0.00 | 0.0% | $0.098 | $0.098 | $0.098 | 0 | |
| $0.098 | +0.019 | +24.1% | $0.071 | $0.098 | $0.059 | 35,900 | |
| $0.079 | +0.02 | +33.9% | $0.079 | $0.079 | $0.079 | 500 | |
| $0.059 | -0.039 | -39.8% | $0.059 | $0.059 | $0.059 | 5,000 | |
| $0.098 | 0.00 | 0.0% | $0.098 | $0.098 | $0.098 | 0 | |
| $0.098 | 0.00 | 0.0% | $0.098 | $0.098 | $0.098 | 0 | |
| $0.098 | 0.00 | 0.0% | $0.098 | $0.098 | $0.098 | 0 | |
| $0.098 | 0.00 | 0.0% | $0.098 | $0.098 | $0.098 | 0 | |
| $0.098 | 0.00 | 0.0% | $0.098 | $0.098 | $0.098 | 0 | |
| $0.098 | -0.002 | -2.0% | $0.098 | $0.098 | $0.098 | 4,500 | |
| $0.10 | 0.00 | 0.0% | $0.10 | $0.10 | $0.10 | 0 | |
| $0.10 | 0.00 | 0.0% | $0.10 | $0.10 | $0.10 | 0 | |
| $0.10 | 0.00 | 0.0% | $0.10 | $0.10 | $0.10 | 0 | |
| $0.10 | 0.00 | 0.0% | $0.10 | $0.10 | $0.10 | 1,000 | |
| $0.10 | 0.00 | 0.0% | $0.10 | $0.10 | $0.10 | 0 | |
| $0.10 | 0.00 | 0.0% | $0.10 | $0.10 | $0.10 | 0 | |
| $0.10 | +0.041 | +69.5% | $0.10 | $0.10 | $0.10 | 300 | |
| $0.059 | -0.03 | -33.7% | $0.06 | $0.06 | $0.059 | 1,200 | |
| $0.089 | 0.00 | 0.0% | $0.089 | $0.089 | $0.089 | 0 | |
| $0.089 | 0.00 | 0.0% | $0.089 | $0.089 | $0.089 | 0 | |
| $0.089 | 0.00 | 0.0% | $0.089 | $0.089 | $0.089 | 250 | |
| $0.089 | -0.011 | -11.0% | $0.06 | $0.089 | $0.06 | 500 | |
| $0.10 | 0.00 | 0.0% | $0.10 | $0.10 | $0.10 | 100 | |
| $0.10 | 0.00 | 0.0% | $0.10 | $0.10 | $0.10 | 0 | |
| $0.10 | +0.013 | +14.9% | $0.059 | $0.10 | $0.059 | 800 | |
| $0.087 | 0.00 | 0.0% | $0.087 | $0.087 | $0.087 | 0 | |
| $0.087 | +0.013 | +17.6% | $0.089 | $0.089 | $0.087 | 1,200 | |
| $0.074 | 0.00 | 0.0% | $0.074 | $0.074 | $0.074 | 0 | |
| $0.074 | 0.00 | 0.0% | $0.074 | $0.074 | $0.074 | 0 | |
| $0.074 | -0.015 | -16.9% | $0.059 | $0.074 | $0.059 | 1,200 | |
| $0.089 | +0.021 | +30.9% | $0.089 | $0.089 | $0.089 | 1,000 | |
| $0.068 | -0.021 | -23.6% | $0.068 | $0.068 | $0.068 | 200 | |
| $0.089 | 0.00 | 0.0% | $0.089 | $0.089 | $0.089 | 775 | |
| $0.089 | 0.00 | 0.0% | $0.089 | $0.089 | $0.089 | 0 | |
| $0.089 | 0.00 | 0.0% | $0.089 | $0.089 | $0.089 | 500 | |
| $0.089 | 0.00 | 0.0% | $0.089 | $0.089 | $0.089 | 0 | |
| $0.089 | 0.00 | 0.0% | $0.089 | $0.089 | $0.089 | 0 | |
| $0.089 | 0.00 | 0.0% | $0.089 | $0.089 | $0.089 | 0 | |
| $0.089 | 0.00 | 0.0% | $0.089 | $0.089 | $0.089 | 0 | |
| $0.089 | 0.00 | 0.0% | $0.089 | $0.089 | $0.089 | 0 | |
| $0.089 | 0.00 | 0.0% | $0.089 | $0.089 | $0.089 | 200 | |
| $0.089 | 0.00 | 0.0% | $0.089 | $0.089 | $0.089 | 0 | |
| $0.089 | +0.007 | +8.5% | $0.09 | $0.09 | $0.074 | 2,300 | |
| $0.082 | 0.00 | 0.0% | $0.082 | $0.082 | $0.082 | 0 | |
| $0.082 | 0.00 | 0.0% | $0.082 | $0.082 | $0.082 | 0 | |
| $0.082 | +0.00 | +0.4% | $0.082 | $0.082 | $0.082 | 0 | |
| $0.082 | +0.007 | +8.9% | $0.059 | $0.082 | $0.059 | 1,275 | |
| $0.075 | +0.016 | +27.1% | $0.075 | $0.075 | $0.075 | 500 |
- Ticker
- OTC:INTI
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- OTC
- Currency
- USD
Inhibitor Therapeutics Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- Decks
- 2 decks · latest March 2024
Valuation
Statements: 4 quarters to Sep 30, 2026 · price Nov 10, 2026
- Enterprise value
- $13.87M USD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- Negative equity
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- Negative equity
- Beta vs S&P 500
- -0.61
Biotechnology: the 10 companies nearest in size, of 891 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Inhibitor Therapeutics Inc. · OTC:INTI | US$13.98M | US$13.87M | n/a | n/a | n/a | n/a | n/a | n/a | -0.61 |
| Hepion Pharmaceuticals, Inc. · OTC:HEPA | US$14.63M | US$10.37M | n/a | n/a | n/a | n/a | n/a | n/a | -1.02 |
| Vectorite Biomedical, Inc. · TPEX:4170 | US$14.21M | US$9.16M | 4.9× | 4.9× | n/a | 0.9× | 156.6% | 0.0× | n/a |
| Estrella Immunopharma, Inc. · NASDAQ:ESLA | US$14.11M | US$14.01M | n/a | n/a | n/a | n/a | n/a | n/a | 1.31 |
| Citius Pharmaceuticals, Inc. · NASDAQ:CTXR | US$13.96M | −US$3.05M | n/a | n/a | n/a | 0.2× | n/a | 0.0× | 1.71 |
| TaiwanJ Pharmaceuticals Co., Ltd. · TPEX:6549 | US$13.69M | US$11.86M | n/a | n/a | n/a | 7.0× | n/a | 0.0× | n/a |
| Actuate Therapeutics, Inc. · NASDAQ:ACTU | US$13.60M | US$11.50M | n/a | n/a | n/a | n/a | n/a | n/a | 1.75 |
| BeyondSpring, Inc. · NASDAQ:BYSI | US$13.57M | US$12.99M | 0.3× | n/a | n/a | 0.9× | n/a | 0.0× | 1.31 |
| Acumen Pharmaceuticals, Inc. · NASDAQ:ABOS | US$13.49M | −US$38.84M | n/a | n/a | n/a | 0.4× | n/a | 0.8× | 1.45 |
| Pharma Equity Group A/S Class A · OMXCOP:PEG | US$13.49M | US$15.06M | n/a | n/a | 52.7× | 3.6× | n/a | 0.4× | n/a |
| BioInvent International AB · OMXSTO:BINV | US$13.48M | −US$6.64M | n/a | −1.7× | n/a | 0.7× | n/a | 0.1× | n/a |
| Median of the others | US$13.64M | US$10.94M | 2.6× | 1.6× | 52.7× | 0.9× | 156.6% | 0.0× | 1.38 |
Team and board
Officers
| Officer | Role |
|---|---|
| Niraj Vasisht | CEO |
| Michelle Yanez | Chief Financial Officer |
| Mike Jerman | CFO |
| Francis E. O’Donnell | Founder/ Executive Officer/ Director |
Board
| Director | Role |
|---|---|
| Ronald E. Osman | Chairman of the Board |
| Samuel Sears | Managing Partner, Chairman of the Corporate Department |
| Francis E. O’Donnell | Founder/ Executive Officer/ Director |
| Michelle Yanez | Chief Financial Officer |
| Niraj Vasisht | CEO |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2025 | Nov 13, 2025 | 0.0% |
| Q2 2025 | Aug 13, 2025 | −20.4% |
| Q1 2025 | May 12, 2025 · Before open | −21.4% |
| Q4 2024 | Mar 27, 2025 · After close | −3.3% |
| Q3 2024 | Nov 11, 2024 · Before open | −2.3% |
| Q2 2024 | Aug 6, 2024 · Before open | 0.0% |
| Q1 2024 | May 13, 2024 · Before open | +14.1% |
| Q4 2023 | Mar 29, 2024 · After close | −2.9% |
| Q3 2023 | Nov 13, 2023 · Before open | −42.3% |
| Q2 2023 | Aug 11, 2023 · Before open | −4.5% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2023 | May 15, 2023 · Before open | 0.0% |
| Q4 2022 | Mar 31, 2023 · After close | +25.0% |
| Q3 2022 | Nov 14, 2022 · After close | +1.7% |
| Q2 2022 | Aug 15, 2022 | 0.0% |
| Q1 2022 | May 12, 2022 | +4.3% |
| Q4 2021 | Feb 24, 2022 | 0.0% |
| Quarter to Sep 30, 2021 | Nov 16, 2021 | 0.0% |
| Quarter to Jun 30, 2021 | Aug 16, 2021 | −7.5% |
| Quarter to Mar 31, 2021 | May 13, 2021 | −2.7% |
| Quarter to Dec 31, 2020 | Feb 25, 2021 | −27.7% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (March 2024) | Investor deck | 29 slides | March 2024 |
| Investor Presentation (August 2019) | Investor deck | 21 slides | Aug 20, 2019 |
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Research and development | 1.70M | 1.76M | 1.38M | 6.15K | 4.91K | 185.3K | 1.21M | 2.63M | 2.23M | 2.64M |
| Operating income | -3.43M | -3.66M | -3.40M | -657.9K | -325.4K | -1.06M | -2.75M | -4.56M | -5.12M | -7.02M |
| Interest expense | 23.2K | 14.8K | ||||||||
| Income before tax | -3.03M | 12.2M | -298.6K | |||||||
| Income tax | 55.1K | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Net income | -3.30M | -3.34M | -3.03M | 12.1M | -298.6K | -1.06M | -2.73M | -4.55M | -5.10M | -7.00M |
| Earnings per share, basic | -0.02 | -0.02 | -0.02 | 0.03 | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 | -0.02 |
| Earnings per share, diluted | -0.02 | -0.02 | -0.02 | 0.03 | 0.00 | 0.00 | -0.01 | -0.01 | -0.01 | -0.02 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.38M | 5.61M | 8.84M | 12.0M | 30.6K | 75.1K | 803.8K | 1.11M | 344.1K | 6.89M |
| Current assets | 2.45M | 5.69M | 8.95M | 12.0M | 58.8K | 107.4K | 846.3K | 1.15M | 655.8K | 7.20M |
| Total assets | 2.51M | 5.69M | 8.95M | 12.0M | 58.8K | 131.8K | 900.0K | 1.23M | 768.1K | 7.34M |
| Accounts payable | 51.5K | 15.9K | 33.7K | 145.2K | 279.8K | 269.4K | 315.9K | 384.8K | 535.0K | 297.8K |
| Current liabilities | 766.3K | 709.6K | 665.2K | 678.8K | 679.6K | 425.4K | 431.1K | 700.6K | 601.5K | 308.1K |
| Long-term debt | 36.9K | |||||||||
| Total debt | 24.7K | |||||||||
| Total liabilities | 3.80M | 3.71M | 3.67M | 3.68M | 3.68M | 3.49M | 3.43M | 1.20M | 601.5K | 308.1K |
| Shareholders' equity | -1.29M | 1.99M | 5.28M | 8.30M | -3.62M | -3.36M | -2.53M | 32.4K | 166.6K | 7.03M |
| Shares outstanding | 172.6M | 172.3M | 172.0M | 171.8M | 376.9M | 373.6M | 370.4M | 370.1M | 369.6M | 353.4M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -3.23M | -3.23M | -2.70M | 11.7M | -220.4K | -825.4K | -2.71M | -3.71M | -2.91M | -3.76M |
| Cash from financing | -411.0K | 180.0K | 176.0K | 96.6K | 2.40M | 4.47M | -3.63M | 10.0M | ||
| Dividends paid | 0 | -99.2K | ||||||||
| Change in cash | -3.23M | -3.23M | -3.11M | 11.9M | -44.4K | -728.8K | -304.9K | 764.6K | -6.54M | 6.28M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-Q · Quarterly report | Nov 16, 2026 | Quarterly report | SEC |
| 8-K · Current report | Sep 18, 2026 | Management or board change | SEC |
| DEF 14A · Proxy statement | Aug 17, 2026 | Meeting notice | SEC |
| 10-Q · Quarterly report | Aug 14, 2026 | Quarterly report | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 4, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 24, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Jun 1, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | May 15, 2026 | Quarterly report | SEC |
| 8-K · Current report | Apr 1, 2026 | Current report | SEC |
| 8-K · Current report | Apr 1, 2026 | Current report | SEC |
| 10-K · Annual report | Mar 25, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 24, 2026 | Material contract | SEC |
| 10-Q · Quarterly report | Nov 13, 2025 | Quarterly report | SEC |
| 8-K · Current report | Oct 24, 2025 | Material contract | SEC |
| UPLOAD · Letter from the SEC | Sep 15, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 13, 2025 | Quarterly report | SEC |
| CORRESP · Letter to the SEC | Jul 22, 2025 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jul 17, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | May 14, 2025 | Quarterly report | SEC |
| 4 · Change in ownership | Apr 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 7, 2025 | Insider trade | SEC |
| 10-K · Annual report | Mar 28, 2025 | Annual report | SEC |
| 5 · Annual statement of ownership | Feb 19, 2025 | Insider trade | SEC |
| 5 · Annual statement of ownership | Feb 19, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 12, 2024 | Quarterly report | SEC |
| 10-Q · Quarterly report | Aug 6, 2024 | Quarterly report | SEC |
| 4 · Change in ownership | May 16, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | May 13, 2024 | Quarterly report | SEC |
| 10-K · Annual report | Mar 29, 2024 | Annual report | SEC |
| 8-K · Current report | Dec 14, 2023 | Material contract | SEC |
| 10-Q · Quarterly report | Nov 13, 2023 | Quarterly report | SEC |
| 8-K · Current report | Oct 18, 2023 | Management or board change | SEC |
| 4 · Change in ownership | Aug 29, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 29, 2023 | Insider trade | SEC |
| 8-K · Current report | Aug 29, 2023 | Management or board change | SEC |
| 10-Q · Quarterly report | Aug 11, 2023 | Quarterly report | SEC |
| 8-K · Current report | May 31, 2023 | Management or board change | SEC |
| SC 13D · Big-stake notice | May 23, 2023 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | May 23, 2023 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | May 22, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 17, 2023 | Insider trade | SEC |
| 3 · Initial statement of ownership | May 17, 2023 | Insider trade | SEC |
| 4 · Change in ownership | May 17, 2023 | Insider trade | SEC |
| SC 13G · Big-stake notice | May 17, 2023 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 15, 2023 | Quarterly report | SEC |
| 10-K · Annual report | Mar 31, 2023 | Annual report | SEC |
| 3 · Initial statement of ownership | Dec 22, 2022 | Insider trade | SEC |
| 3 · Initial statement of ownership | Dec 22, 2022 | Insider trade | SEC |
| 3 · Initial statement of ownership | Dec 22, 2022 | Insider trade | SEC |
| 3 · Initial statement of ownership | Dec 22, 2022 | Insider trade | SEC |
| 3 · Initial statement of ownership | Dec 22, 2022 | Insider trade | SEC |
| 8-K · Current report | Dec 19, 2022 | Material contract | SEC |
| 10-Q · Quarterly report | Nov 14, 2022 | Quarterly report | SEC |
| 8-K · Current report | Sep 15, 2022 | Current report | SEC |
| 10-Q · Quarterly report | Aug 12, 2022 | Quarterly report | SEC |
| 8-K · Current report | Jun 3, 2022 | Management or board change | SEC |
| 10-Q · Quarterly report | May 13, 2022 | Quarterly report | SEC |
| 10-K · Annual report | Mar 30, 2022 | Annual report | SEC |
| 8-K · Current report | Jan 18, 2022 | Material contract | SEC |
| 10-Q · Quarterly report | Nov 12, 2021 | Quarterly report | SEC |
| 10-Q · Quarterly report | Aug 13, 2021 | Quarterly report | SEC |
| 10-Q · Quarterly report | May 14, 2021 | Quarterly report | SEC |
| 10-K · Annual report | Mar 26, 2021 | Annual report | SEC |
| 4 · Change in ownership | Jan 19, 2021 | Insider trade | SEC |
| 8-K · Current report | Jan 6, 2021 | Management or board change | SEC |
| 4 · Change in ownership | Dec 28, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Dec 28, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Dec 28, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Dec 28, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Dec 28, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Dec 28, 2020 | Insider trade | SEC |
| 8-K · Current report | Dec 17, 2020 | Material contract | SEC |
| 10-Q · Quarterly report | Nov 16, 2020 | Quarterly report | SEC |
| 8-K · Current report | Sep 23, 2020 | Management or board change | SEC |
| 4 · Change in ownership | Sep 21, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Sep 21, 2020 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 12, 2020 | Quarterly report | SEC |
| 4 · Change in ownership | Jul 20, 2020 | Insider trade | SEC |
| 8-K · Current report | Jun 30, 2020 | Management or board change | SEC |
| 8-K · Current report | Jun 8, 2020 | Current report | SEC |
| 8-K · Current report | May 6, 2020 | Material contract | SEC |
| 10-Q · Quarterly report | May 1, 2020 | Quarterly report | SEC |
| 8-K · Current report | Apr 16, 2020 | Management or board change | SEC |
| 10-K · Annual report | Mar 30, 2020 | Annual report | SEC |
| 4 · Change in ownership | Mar 24, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Mar 24, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Mar 24, 2020 | Insider trade | SEC |
| 4 · Change in ownership | Mar 24, 2020 | Insider trade | SEC |
| 5 · Annual statement of ownership | Feb 10, 2020 | Insider trade | SEC |
| 8-K · Current report | Jan 3, 2020 | Management or board change | SEC |
| 4 · Change in ownership | Dec 16, 2019 | Insider trade | SEC |
| DEF 14C | Dec 5, 2019 | Meeting notice | SEC |
| 4 · Change in ownership | Dec 2, 2019 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 7, 2019 | Quarterly report | SEC |
| 3 · Initial statement of ownership | Nov 1, 2019 | Insider trade | SEC |
| 8-K · Current report | Oct 31, 2019 | Management or board change | SEC |
| 8-K · Current report | Aug 27, 2019 | Material contract | SEC |
| 8-K · Current report | Aug 20, 2019 | Current report | SEC |
| 10-Q · Quarterly report | Aug 12, 2019 | Quarterly report | SEC |
| 8-K · Current report | Jul 17, 2019 | Current report | SEC |
| 8-K · Current report | Jul 1, 2019 | Management or board change | SEC |
| 8-K · Current report | Jun 19, 2019 | Current report | SEC |
| 4 · Change in ownership | Jun 10, 2019 | Insider trade | SEC |
| DEF 14C | Jun 3, 2019 | Meeting notice | SEC |
| PRE 14C | May 24, 2019 | Meeting notice | SEC |
| 10-Q · Quarterly report | May 9, 2019 | Quarterly report | SEC |
| EFFECT · Notice that a registration is effective | May 1, 2019 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Apr 26, 2019 | Offer document | SEC |
| 8-K · Current report | Apr 15, 2019 | Current report | SEC |
| CT ORDER | Apr 1, 2019 | Other filings | SEC |
| 10-K · Annual report | Mar 7, 2019 | Annual report | SEC |
| 8-K · Current report | Feb 13, 2019 | Current report | SEC |
| 4 · Change in ownership | Feb 5, 2019 | Insider trade | SEC |
| 4 · Change in ownership | Feb 5, 2019 | Insider trade | SEC |
| 4 · Change in ownership | Feb 5, 2019 | Insider trade | SEC |
| 4 · Change in ownership | Feb 5, 2019 | Insider trade | SEC |
| 4 · Change in ownership | Jan 24, 2019 | Insider trade | SEC |
| DEF 14C | Jan 8, 2019 | Meeting notice | SEC |
| 8-K · Current report | Dec 31, 2018 | Material contract | SEC |
| PRE 14C | Dec 28, 2018 | Meeting notice | SEC |
| 4 · Change in ownership | Dec 26, 2018 | Insider trade | SEC |
| 4 · Change in ownership | Dec 26, 2018 | Insider trade | SEC |
| DEF 14C | Dec 21, 2018 | Meeting notice | SEC |
| 4 · Change in ownership | Dec 19, 2018 | Insider trade | SEC |
| SC 13D/A · Big-stake notice, amended | Dec 19, 2018 | Big-stake notice | SEC |
| 8-K · Current report | Dec 17, 2018 | Material contract | SEC |
| 10-Q · Quarterly report | Nov 14, 2018 | Quarterly report | SEC |
| 8-K · Current report | Nov 5, 2018 | Current report | SEC |
| SC 13D/A · Big-stake notice, amended | Nov 5, 2018 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 31, 2018 | Insider trade | SEC |
| 10-Q · Quarterly report | Jul 23, 2018 | Quarterly report | SEC |
| 8-K · Current report | Jul 10, 2018 | Financing | SEC |
| 4 · Change in ownership | Jul 6, 2018 | Insider trade | SEC |
| SC 13D/A · Big-stake notice, amended | Jul 6, 2018 | Big-stake notice | SEC |
| 10-Q · Quarterly report | May 1, 2018 | Quarterly report | SEC |
| EFFECT · Notice that a registration is effective | Apr 18, 2018 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Apr 4, 2018 | Offer document | SEC |
| 4 · Change in ownership | Mar 15, 2018 | Insider trade | SEC |
| 4 · Change in ownership | Mar 15, 2018 | Insider trade | SEC |
| 4 · Change in ownership | Mar 15, 2018 | Insider trade | SEC |
| 4 · Change in ownership | Mar 15, 2018 | Insider trade | SEC |
| 4 · Change in ownership | Mar 15, 2018 | Insider trade | SEC |
| 4 · Change in ownership | Mar 15, 2018 | Insider trade | SEC |
| 10-K · Annual report | Feb 16, 2018 | Annual report | SEC |
| 4 · Change in ownership | Feb 12, 2018 | Insider trade | SEC |
| 4 · Change in ownership | Feb 12, 2018 | Insider trade | SEC |
| CT ORDER | Jan 22, 2018 | Other filings | SEC |
| 4 · Change in ownership | Jan 11, 2018 | Insider trade | SEC |
| SC 13D/A · Big-stake notice, amended | Jan 11, 2018 | Big-stake notice | SEC |
| 8-K · Current report | Jan 11, 2018 | Material contract | SEC |
| 8-K · Current report | Dec 20, 2017 | Meeting outcome | SEC |
| DEF 14A · Proxy statement | Nov 13, 2017 | Meeting notice | SEC |
| 10-Q · Quarterly report | Oct 31, 2017 | Quarterly report | SEC |
| 8-K · Current report | Oct 5, 2017 | Current report | SEC |
| 10-Q · Quarterly report | Jul 31, 2017 | Quarterly report | SEC |
| SC 13D/A · Big-stake notice, amended | Jul 27, 2017 | Big-stake notice | SEC |
| 8-K · Current report | Jul 27, 2017 | Current report | SEC |
| 4 · Change in ownership | Jul 19, 2017 | Insider trade | SEC |
| 4 · Change in ownership | Jul 19, 2017 | Insider trade | SEC |
| 4 · Change in ownership | Jul 12, 2017 | Insider trade | SEC |
| 8-K · Current report | May 30, 2017 | Current report | SEC |
| 10-Q · Quarterly report | May 8, 2017 | Quarterly report | SEC |
| EFFECT · Notice that a registration is effective | Apr 26, 2017 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Apr 21, 2017 | Offer document | SEC |
| 4 · Change in ownership | Mar 10, 2017 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2017 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2017 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2017 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2017 | Insider trade | SEC |
| 10-K · Annual report | Feb 17, 2017 | Annual report | SEC |
| 8-K · Current report | Jan 24, 2017 | Current report | SEC |
| 3 · Initial statement of ownership | Dec 6, 2016 | Insider trade | SEC |
| DEF 14C | Dec 5, 2016 | Meeting notice | SEC |
| 8-K · Current report | Dec 2, 2016 | Management or board change | SEC |
| SC 13D/A · Big-stake notice, amended | Dec 2, 2016 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Nov 30, 2016 | Insider trade | SEC |
| 8-K · Current report | Nov 28, 2016 | Material contract | SEC |
| SC 13D/A · Big-stake notice, amended | Nov 28, 2016 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 15, 2016 | Insider trade | SEC |
| SC 13D/A · Big-stake notice, amended | Nov 15, 2016 | Big-stake notice | SEC |
| 8-K · Current report | Nov 8, 2016 | Current report | SEC |
| SC 13D/A · Big-stake notice, amended | Nov 7, 2016 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 7, 2016 | Insider trade | SEC |
| 10-Q · Quarterly report | Oct 31, 2016 | Quarterly report | SEC |
| S-8 · Registration statement for employee plans | Oct 24, 2016 | Offer document | SEC |
| 10-Q · Quarterly report | Aug 12, 2016 | Quarterly report | SEC |
| 424B3 · Prospectus | Jul 26, 2016 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Jul 25, 2016 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jul 21, 2016 | Other filings | SEC |
This page holds 200 of 725 filings. Open Filings
Cap table
Built by 6ix from Inhibitor Therapeutics Inc.’s releases
- Common shares
- 174,781,968
- Fully diluted
- 174,781,968
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 174,781,968 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 174,781,968 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Michael Jerman Other companies: Alaunos Therapeutics, Inc. (Managing Partner of Hollywell Partners · Since at least Jul 15, 2025); Telomir Pharmaceuticals, Inc. (Director · Feb 8, 2024 – Aug 27, 2024 · Past); MIRA Pharmaceuticals, Inc. (Director · Nov 14, 2023 – Mar 25, 2024 · Past) | Director · Since at least Apr 1, 2024 |
| W. Mark Watson Other companies: Vaxart, Inc. (Lead Independent Director · Since at least Aug 4, 2022); Sykes Enterprises Incorporated (Director · May 22, 2018 – Aug 27, 2021 · Past); BioDelivery Sciences International Inc (Director · Dec 8, 2016 – Mar 22, 2022 · Past) | Director · Aug 14, 2015 – Dec 22, 2020 · Past |
| James A. McNulty Other companies: Lunai Bioworks Inc. (Director · Since at least Oct 14, 2024); CV Sciences, Inc. (Director · Feb 5, 2018 – Jun 16, 2020 · Past) | Chief Financial Officer · Since at least Dec 13, 2022 |
| Michelle Yanez Other companies: Telomir Pharmaceuticals, Inc. (Chief Financial Officer · Jun 18, 2024 – Aug 27, 2024 · Past); MIRA Pharmaceuticals, Inc. (Chief Financial Officer · Aug 2, 2023 – Dec 9, 2024 · Past) | Director · Since at least Dec 13, 2022 |
| Francis E Odonnell Jr Other companies: BioDelivery Sciences International Inc (Director · Jun 15, 2016 – May 11, 2020 · Past) | Chief Executive Officer, Director · Since at least Jun 6, 2016 |
| Niraj Vasisht Other companies: BioDelivery Sciences International Inc (SVP & Chief Technology Officer · Jan 1, 2016 – Mar 24, 2017 · Past) | CEO · Since at least Dec 13, 2022 |
| Richard Dana Ono Other companies: Lipocine Inc. (Director · Since at least Jan 6, 2014) | Director · Jun 24, 2014 – Dec 22, 2020 · Past |
| Samuel P Sears Jr Other companies: BioDelivery Sciences International Inc (Director · Oct 19, 2011 – Nov 15, 2017 · Past) | Director · Since at least Jan 10, 2006 |
| Daniel O Hayden | Director · Mar 27, 2007 – Mar 27, 2007 · Past |
| Debra Peattie | Director · Oct 30, 2019 – Dec 22, 2020 · Past |
All 26 people
| Person | Seat |
|---|---|
| E Brendan Magrab | Director · Nov 22, 2016 – Feb 3, 2019 · Past |
| Francis E. O’Donnell | Founder/ Executive Officer/ Director · Since at least Nov 5, 2026 |
| Garrison J Hasara | CFO and Treasurer · Dec 22, 2020 – Dec 22, 2020 · Past |
| Gerald P Krueger | Director · Apr 19, 2006 – May 15, 2006 · Past |
| James D Causey | Director · Dec 31, 2007 – Dec 31, 2007 · Past |
| James H Brennan | VP Financial Operations · Dec 15, 2005 – Dec 29, 2008 · Past |
| Mike Jerman | CFO · Since at least Nov 4, 2026 |
| Nicholas J Virca | President and CEO · Dec 22, 2020 – Dec 22, 2020 · Past |
| Richard J Freer | Chief Executive Officer, Director · Jan 3, 2006 – Apr 12, 2013 · Past |
| Robert B Harris | President · Jan 3, 2006 – Dec 29, 2008 · Past |
| Robert Daniel Martin | Director · Nov 30, 2016 – Dec 22, 2020 · Past |
| Ronald E. Osman | Chairman of the Board · Since at least May 5, 2023 |
| Samuel Sears | Managing Partner, Chairman of the Corporate Department · Since at least Nov 5, 2026 |
| Stefan Cross | Director · Jun 24, 2014 – Dec 19, 2017 · Past |
| Thomas R Reynolds | Executive VP · Jan 3, 2006 – Dec 29, 2008 · Past |
| William X Guo | Chairman, Director · Sep 12, 2008 – Sep 12, 2008 · Past |
Log in to ask 6ix AI your own questions about Inhibitor Therapeutics Inc.